TR201619983A2 - Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari - Google Patents

Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari Download PDF

Info

Publication number
TR201619983A2
TR201619983A2 TR2016/19983A TR201619983A TR201619983A2 TR 201619983 A2 TR201619983 A2 TR 201619983A2 TR 2016/19983 A TR2016/19983 A TR 2016/19983A TR 201619983 A TR201619983 A TR 201619983A TR 201619983 A2 TR201619983 A2 TR 201619983A2
Authority
TR
Turkey
Prior art keywords
eletriptan
diclofenac
pharmaceutical formulations
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
TR2016/19983A
Other languages
English (en)
Inventor
Dedeoğlu Yavuz
Zengi̇ner Si̇bel
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2016/19983A priority Critical patent/TR201619983A2/tr
Priority to EP17210906.8A priority patent/EP3342404A1/en
Priority to PCT/EP2017/084742 priority patent/WO2018122330A1/en
Publication of TR201619983A2 publication Critical patent/TR201619983A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş diklofenak veya farmasötik olarak kabul edilebilir bir tuzunun eletriptan veya farmasötik olarak kabul edilebilir bir tuzuyla kombinasyonunu ve en az bir farmasötik olarak kabul edilebilir yardımcı madde içeren bir farmasötik kompozisyonla ilgilidir.
TR2016/19983A 2016-12-29 2016-12-29 Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari TR201619983A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2016/19983A TR201619983A2 (tr) 2016-12-29 2016-12-29 Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari
EP17210906.8A EP3342404A1 (en) 2016-12-29 2017-12-28 Pharmaceutical compositions of diclofenac and eletriptan
PCT/EP2017/084742 WO2018122330A1 (en) 2016-12-29 2017-12-28 Pharmaceutical compositions of diclofenac and eletriptan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/19983A TR201619983A2 (tr) 2016-12-29 2016-12-29 Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari

Publications (1)

Publication Number Publication Date
TR201619983A2 true TR201619983A2 (tr) 2018-07-23

Family

ID=60813750

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/19983A TR201619983A2 (tr) 2016-12-29 2016-12-29 Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari

Country Status (3)

Country Link
EP (1) EP3342404A1 (tr)
TR (1) TR201619983A2 (tr)
WO (1) WO2018122330A1 (tr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
HU225055B1 (en) 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
EP2023894A4 (en) * 2006-04-25 2010-10-20 Applied Pharma Res FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
AU2009260166B2 (en) 2008-06-20 2014-10-09 Alphapharm Pty Ltd Pharmaceutical formulation

Also Published As

Publication number Publication date
WO2018122330A1 (en) 2018-07-05
EP3342404A1 (en) 2018-07-04

Similar Documents

Publication Publication Date Title
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
CO2017013293A2 (es) Formulaciones farmacéuticas que comprenden tenofovir y emtricitabina
IL264065A (en) Oral gastroretentive formulations and uses thes thereof
BR112015020466A8 (pt) inibidores de cdc7, seus usos, e composição farmacêutica
MY196173A (en) Cot Modulators And Methods Of Use Thereof
MX2020011104A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
CL2016001424A1 (es) Composiciones de liberación retardada de lionaclotida
BR112017028140A2 (pt) formulações farmacêuticas
MX392199B (es) Composiciones farmaceuticas para terapia de combinacion
MA41159A (fr) Octréotide destiné à être administré par voie orale en association avec d'autres agents thérapeutiques
UY36117A (es) Composiciones farmacéuticas para el tratamiento de enfermedades infecciosas.
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
EA201991287A1 (ru) Твердые фармацевтические композиции на основе тикагрелора для перорального применения
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos
UA116499C2 (uk) (r)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
MX374340B (es) Administracion de farmacos antiinflamatorios no esteroidales y composiciones, metodos y sistemas relacionados.
MX2019009909A (es) Composiciones farmaceuticas para terapia de combinacion.
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
PE20170305A1 (es) Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
TR201821114A2 (tr) Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m
EA201991007A1 (ru) Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения
MX2018004532A (es) Combinacion de trazodona y gabapentina para el tratamiento de dolor.
MX384394B (es) Compuesto para uso en la prevención y tratamiento de enfermedades neurodegenerativas.
EA201890122A1 (ru) Применение 2-(5s-метил-2-оксо-4r-фенилпирролидин-1-ил)ацетамида в лечении судорог